Lamivudine
Dosing in kidney impairment
Patients with Renal Impairment Dosage recommendations for adult patients with reduced renal function are provided in Table 1 [see Clinical Pharmacology] . Table 1. Dosage of Lamivudine Tablets (HBV) in Adult Patients with Renal Impairment [See table below.] Following correction of the dosage for renal impairment, no additional dosage modification of lamivudine tablets (HBV) is required after routine (4-hour) hemodialysis or peritoneal dialysis [see Clinical Pharmacology ] .
There are insufficient data to recommend a specific dosage of lamivudine tablets (HBV) in pediatric patients with renal impairment.
Preparation and administration
Important Administration Instructions
Lamivudine tablets (HBV) may be administered with or without food.
The tablets and oral solution may be used interchangeably [see Clinical Pharmacology].
The oral solution should be used for doses less than 100 mg.
Lamivudine tablets (HBV) should not be used with other medications that contain lamivudine or medications that contain emtricitabine.